Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

424 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Efficacy of different rituximab therapeutic strategies in patients with neuromyelitis optica spectrum disorders.
Novi G, Bovis F, Capobianco M, Frau J, Mataluni G, Curti E, Zuliani L, Cavalla P, Brambilla L, Annovazzi P, Repice AM, Lanzillo R, Esposito S, Benedetti L, Maietta I, Sica F, Buttari F, Malucchi S, Fenu G, Landi D, Bosa C, Realmuto S, Malentacchi M, Granella F, Signori A, Bonavita S, Uccelli A, Sormani MP; iMUST group. Novi G, et al. Among authors: benedetti l. Mult Scler Relat Disord. 2019 Nov;36:101430. doi: 10.1016/j.msard.2019.101430. Epub 2019 Oct 4. Mult Scler Relat Disord. 2019. PMID: 31610404
Long-term effect of rituximab in anti-mag polyneuropathy.
Benedetti L, Briani C, Franciotta D, Carpo M, Padua L, Zara G, Zambello R, Sormani MP, Mancardi GL, Nobile-Orazio E, Schenone A. Benedetti L, et al. Neurology. 2008 Nov 18;71(21):1742-4. doi: 10.1212/01.wnl.0000335268.70325.33. Neurology. 2008. PMID: 19015493 No abstract available.
IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy.
Campagnolo M, Zambello R, Nobile-Orazio E, Benedetti L, Marfia GA, Riva N, Castellani F, Bianco M, Salvalaggio A, Garnero M, Ruiz M, Mataluni G, Fazio R, Ermani M, Briani C. Campagnolo M, et al. Among authors: benedetti l. J Neurol Neurosurg Psychiatry. 2017 Dec;88(12):1094-1097. doi: 10.1136/jnnp-2017-315736. Epub 2017 May 13. J Neurol Neurosurg Psychiatry. 2017. PMID: 28501820 No abstract available.
Tocilizumab in MOG-antibody spectrum disorder: a case report.
Novi G, Gastaldi M, Franciotta D, Pesce G, Benedetti L, Uccelli A. Novi G, et al. Among authors: benedetti l. Mult Scler Relat Disord. 2019 Jan;27:312-314. doi: 10.1016/j.msard.2018.11.012. Epub 2018 Nov 13. Mult Scler Relat Disord. 2019. PMID: 30469022
Cell-based assays for the detection of MOG antibodies: a comparative study.
Gastaldi M, Scaranzin S, Jarius S, Wildeman B, Zardini E, Mallucci G, Rigoni E, Vegezzi E, Foiadelli T, Savasta S, Banfi P, Versino M, Benedetti L, Novi G, Mancardi MM, Giacomini T, Annovazzi P, Baroncini D, Ferraro D, Lampasona V, Reindl M, Waters P, Franciotta D. Gastaldi M, et al. Among authors: benedetti l. J Neurol. 2020 Dec;267(12):3555-3564. doi: 10.1007/s00415-020-10024-0. Epub 2020 Jul 4. J Neurol. 2020. PMID: 32623596
424 results